Search

Introduction: Perinatal morbidity and mortality is one of the main indicators of social development in any country. The main causes of neonatal morbidity are intrinsically related to the health of the mother and the attention she receives. Hence, the importance of timely recognizing and treating these diseases in the mother to help prevent morbidity in our neonatal patients. Objective: To determine the prevalence of perinatal morbidity during pregnancy of mothers who receive care in the "Dr. Jose Eleuterio González" University Hospital of the Universidad Autónoma de Nuevo León. Material and methods: Observational, retrospective, analytical study, which included all infants with 37 weeks gestation or more who were born from November 1, 2010 to April 30, 2011. The sample was divided into six groups for its statistical analysis and divided based on perinatal morbidity. Group A: macrosomic products, group B: hypotrophic newborn, group C: history of meconium stained fluid, group D: potentially septic, group E: child of Rh negative mother and group F: infant of diabetic mother. Results: Urinary tract infection was the most prevalent maternal disease with 11.1%, associated with the macrosomic group in 20% (p<0.05). The hypotrophic group had the highest admission to the NICU with 15. The group with meconium-stained amniotic fluid had a higher prevalence of cervical infections with 5.4% (p<0.05). The group of infants of a diabetic mother had the highest rate of maternal age with 31 ± 6.82 years (p<0.001) and a total of 75.9% of cesarean section for the same group (p<0.05) Conclusions: The morbidity of mothers who are treated in our hospital is 22%, 7.3% of term infants born to mothers with morbidity during pregnancy were admitted to the NICU and mortality in the NICU of children of mothers with perinatal morbidity was 5.5%. [ABSTRACT FROM AUTHOR]

Introduction: There are no studies analyzing therapeutic practices of Mexican neurologists in the treatment of migraine. Objective: To analyze therapeutic practices of neurologists in the treatment of migraine. Methods: We surveyed adult neurologists (AN) and pediatric neurologists (PN) in order to know their therapeutic practices, based on hypothetical clinical cases and direct questions on pharmacologic and non-pharmacologic treatment. Results: The response rate was 14% and 16% for AN and PN, respectively. A 56% of NA would use a triptan for a short-lasting episode (< 1 h). In all, 78% of PN would use analgesics for attacks lasting < 1 h, and triptans or analgesics (both type of neurologists in 30%) for attacks lasting 1-4 h. Prophylactic drug use was as follows: topiramate (both AN and NP in 30%), propranolol (AN: 27%, PN: 15%), and calcium channel blockers (AN: 8%, PN: 22%). BonTA has been used by 27% of AN. Non-pharmacologic measures were widely used by both type of neurologists. Conclusions: The clinical practice of Mexican AN with respect to migraine treatment is similar to that of their counterparts around the world. It was observed an adoption of the use of clinical guidelines for AN to the clinical practice of PN. [ABSTRACT FROM AUTHOR]